Cough suppressant abuse may lead to dispensing restrictions

08/31/2010 | Bloomberg

The FDA might review cough medications from Pfizer and Johnson & Johnson for possible dispensing restrictions, after the agency found an increased number of emergency department visits associated with misuse of dextromethorphan from 2004 to 2008. An FDA advisory panel is scheduled Sept. 14 to discuss whether the common cough suppressant should be a controlled substance.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA